Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Report By Treatment (Medication, Stem Cell Transplant, And Blood Transfusion) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026
ID:VMR11210464
January 2020
Report Formats:

As per this study, the Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

Paroxysmal Nocturnal Hemoglobinuria (PNH) is a chronic hematological disorder, i.e. disorder which primarily affects the blood. It is an ultra-rare disease of bone marrow stem cells which affects more than 20,000 people globally. This disease affects men and women equally. Physical symptoms can begin at any age, they usually develop between 30-40 years of age. The only curative therapy for PNH patients is allogeneic stem cell transplantation.
 
Market Dynamics
 
The rise in a number of blood and bone marrow related disorders and increase in geriatric population are the key factors which drive the market growth of PNH treatment market. In addition to this, the emergence of biologics and adoption of novel therapeutics are further pushing the market growth. However, adverse effects associated with currently available treatments, increase in the cost of medical equipment, specifically surgical equipment required for stem cell transformation are some factors that restrain market growth of PNH.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of paroxysmal nocturnal hemoglobinuria (PNH) treatment.
 
Market Segmentation
 
The broad paroxysmal nocturnal hemoglobinuria (PNH) treatment market has been sub-grouped into treatment. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Treatment

  • Medication
  • Stem Cell Transplant
  • Blood Transfusion
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for paroxysmal nocturnal hemoglobinuria (PNH) treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the paroxysmal nocturnal hemoglobinuria (PNH) treatment market include Alexion Pharmaceuticals, Inc., Akari Therapeutics, Plc, Apellis Pharmaceuticals, Inc.,  Amgen, Inc., Alnylam Pharmaceuticals, Inc., CinnaGen Co., Plc, Ra Pharmaceuticals, Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
       2.2. Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Snapshot
 
3 . PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
       3.3. Market Restraints of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
       3.4. Opportunities of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
       3.5. Trends of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
       3.6. Porter’s Five Force Analysis of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
       3.7. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Treatment
           3.7.2 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Value Chain Analysis
       4.2. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET ANALYSIS BY TREATMENT
       5.1 Overview by Treatment
       5.2 Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment
       5.3 Market Analysis of Medication by Regions
       5.4 Market Analysis of Stem Cell Transplant by Regions
       5.5 Market Analysis of Blood Transfusion by Regions
 
6 . GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       6.1. Regional Outlook
       6.2. Introduction
       6.3. North America
           6.3.1. Overview
           6.3.2. North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
           6.3.3. North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
           6.3.4. United State
           6.3.5. Rest of North America
       6.4. Europe
           6.4.1. Overview
           6.4.2. Europe Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
           6.4.3. Europe Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
           6.4.4. United Kingdom
           6.4.5. France
           6.4.6. Germany
           6.4.6 Rest of Europe
       6.5. Asia Pacific
           6.5.1. Overview
           6.5.2. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
           6.5.3. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
           6.5.4. China
           6.5.5. Japan
           6.5.6. India
           6.5.6. Rest of Asia Pacific
       6.6. Latin America
           6.6.1. Overview
           6.6.2. Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
           6.6.3. Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
           6.6.4. Brazil
           6.6.5. Rest of Latin America
       6.7. Middle East & Africa
           6.7.1. Overview
           6.7.2. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
           6.7.3. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
           6.7.4. Middle East
           6.7.5. Africa
 
7 . COMPETITIVE LANDSCAPE OF THE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT COMPANIES
       7.1. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Competition
       7.2. Partnership/Collaboration/Agreement
       7.3. Merger And Acquisitions
       7.4. New Product Launch
       7.5. Other Developments
 
8 . COMPANY PROFILES OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT INDUSTRY
       8.1. Company Share Analysis
       8.2. Market Concentration Rate
       8.3. Alexion Pharmaceuticals, Inc.
           8.3.1. Company Overview
           8.3.2. Financials
           8.3.3. Products
           8.3.4. Recent Developments
       8.4. Akari Therapeutics
           8.4.1. Company Overview
           8.4.2. Financials
           8.4.3. Products
           8.4.4. Recent Developments
       8.5. Apellis Pharmaceuticals, Inc.
           8.5.1. Company Overview
           8.5.2. Financials
           8.5.3. Products
           8.5.4. Recent Developments
       8.6. Amgen, Inc.
           8.6.1. Company Overview
           8.6.2. Financials
           8.6.3. Products
           8.6.4. Recent Developments
       8.7. Alnylam Pharmaceuticals, Inc.
           8.7.1. Company Overview
           8.7.2. Financials
           8.7.3. Products
           8.7.4. Recent Developments
       8.8. CinnaGen Co, Plc
           8.8.1. Company Overview
           8.8.2. Financials
           8.8.3. Products
           8.8.4. Recent Developments
       8.9. Ra Pharmaceuticals, Inc.
           8.9.1. Company Overview
           8.9.2. Financials
           8.9.3. Products
           8.9.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES

  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Snapshot
  •  Drivers of The Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Impact Analysis
  •  Restraints of The Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Medication by Geography (USD MN)
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Stem Cell Transplant by Geography (USD MN)
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Blood Transfusion by Geography (USD MN)
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market by Geography (USD MN)
  •  North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country (USD MN)
  •  United State Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Rest of North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Europe Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  United Kingdom Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  France Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Germany Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Rest of Europe Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country (USD MN)
  •  China Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Japan Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  India Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Rest of Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country (USD MN)
  •  Brazil Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Rest of Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Treatment (USD MN)
  •  Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country (USD MN)
  •  Middle East Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
  •  Research Scope of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Treatment
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Medication by Geography (USD MN)
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Stem Cell Transplant by Geography (USD MN)
  •  Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Blood Transfusion by Geography (USD MN)
  •  Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market by Revenue
  •  Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market by Revenue
  •  Recent Development in Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Industry
  •  Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials